Preclinical safety and efficacy of 24R,25-dihydroxyvitamin D3 or lactosylceramide treatment to enhance fracture repair

Background/Objective: Cyp24a1-null mice deficient in 24,25(OH)2D3 display impaired callus formation during the endochondral phase of bone fracture repair. The 24,25(OH)2D3 metabolite acted by binding to the TLC domain containing 3B isoform 2 (TLCD3B2, previously named FAM57B2) effector protein, whic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Corine Martineau, Martin Kaufmann, Alice Arabian, Glenville Jones, René St-Arnaud
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020-07-01
Colecção:Journal of Orthopaedic Translation
Assuntos:
24,25-dihydroxyvitamin D
Bone
Family with sequence similarity 57B, isoform 2 (FAM57B2)
Fracture
Lactosylceramide
Repair
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2214031X20300437
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados